Xometry, Inc. (NASDAQ:XMTR) Stock Has Average Target Price of $113.18

Key Points

• Analysts have a “Moderate Buy” consensus on Xometry, with eight buy, four hold and one sell rating. The average 12-month price target is $113.18, above the stock’s reported $90.05 price.
• Xometry exceeded quarterly expectations, reporting $0.16 in EPS versus $0.15 expected and $229.28 million in revenue versus $215.22 million forecast. Revenue increased 41.1% year over year, although the company remained unprofitable.
• Institutional investors own 97.31% of the stock, while insiders own 9.10%; insiders sold 64,699 shares worth approximately $6.17 million during the latest quarter.

Xometry, Inc. (NASDAQ:XMTR - Get Free Report) has earned a consensus rating of "Moderate Buy" from the thirteen analysts that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have given a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $113.18.

Several brokerages recently issued reports on XMTR. JPMorgan Chase & Co. assumed coverage on Xometry in a report on Monday, August 24th. They set an "overweight" rating and a $120.00 price objective for the company. Rosenblatt Securities upped their target price on Xometry from $110.00 to $120.00 and gave the company a "buy" rating in a report on Tuesday, September 22nd. Raymond James Financial set a $120.00 price target on Xometry in a research report on Tuesday, September 22nd. UBS Group raised their price target on Xometry from $88.00 to $95.00 and gave the company a "neutral" rating in a research report on Wednesday, August 5th. Finally, The Goldman Sachs Group lifted their price target on Xometry from $78.00 to $104.00 and gave the stock a "neutral" rating in a research note on Wednesday, August 5th.

Insider Buying and Selling at Xometry

In other Xometry news, CEO Sanjeev Sahni sold 1,500 shares of the firm's stock in a transaction dated Monday, October 12th. The shares were sold at an average price of $108.80, for a total transaction of $163,200.00. Following the completion of the transaction, the chief executive officer directly owned 178,291 shares in the company, valued at approximately $19,398,060.80. This trade represents a 0.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CTO Vaidyanathan Raghavan sold 1,866 shares of the firm's stock in a transaction dated Friday, October 2nd. The shares were sold at an average price of $103.28, for a total transaction of $192,720.48. Following the transaction, the chief technology officer owned 133,911 shares of the company's stock, valued at $13,830,328.08. This trade represents a 1.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 64,699 shares of company stock valued at $6,169,735 in the last quarter. Insiders own 9.10% of the company's stock.

Institutional Trading of Xometry

Several large investors have recently modified their holdings of the business. Park Avenue Securities LLC purchased a new stake in Xometry in the 3rd quarter valued at approximately $691,000. Capelight Capital Asset Management LP grew its holdings in Xometry by 20.7% during the 3rd quarter. Capelight Capital Asset Management LP now owns 36,200 shares of the company's stock valued at $3,723,000 after buying an additional 6,200 shares during the last quarter. Sterling Capital Management LLC grew its holdings in Xometry by 949.7% during the 3rd quarter. Sterling Capital Management LLC now owns 1,711 shares of the company's stock valued at $176,000 after buying an additional 1,548 shares during the last quarter. Inspire Investing LLC purchased a new position in Xometry during the third quarter worth $631,000. Finally, Abel Hall LLC increased its position in Xometry by 5.2% during the third quarter. Abel Hall LLC now owns 2,246 shares of the company's stock worth $231,000 after buying an additional 111 shares in the last quarter. 97.31% of the stock is currently owned by institutional investors and hedge funds.

Xometry Stock Up 1.3%

XMTR stock opened at $90.05 on Tuesday. The company has a current ratio of 3.21, a quick ratio of 3.20 and a debt-to-equity ratio of 0.41. The company's 50-day moving average price is $95.17 and its 200 day moving average price is $75.40. Xometry has a 52 week low of $35.86 and a 52 week high of $112.94. The company has a market cap of $4.67 billion, a P/E ratio of -150.08 and a beta of 1.23.

Xometry (NASDAQ:XMTR - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.15 by $0.01. The company had revenue of $229.28 million during the quarter, compared to analysts' expectations of $215.22 million. Xometry had a negative net margin of 3.82% and a negative return on equity of 2.88%. The firm's quarterly revenue was up 41.1% compared to the same quarter last year. During the same period last year, the company posted $0.09 earnings per share. On average, research analysts expect that Xometry will post -0.01 earnings per share for the current fiscal year.

Xometry Company Profile

Xometry, Inc NASDAQ: XMTR operates a technology-driven marketplace that connects businesses seeking custom parts with a network of manufacturing suppliers. Its platform uses automated pricing, manufacturability analysis and digital workflows to help customers source parts and manage production more efficiently.

The company supports a range of manufacturing processes, including CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other specialized production services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.